Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of Affective Disorders, 339, 860–866. https://doi.org/10.1016/j.jad.2023.07.071

Article  PubMed  Google Scholar 

Bostwick, J. M., & Pankratz, V. S. (2000). Affective disorders and suicide risk: A reexamination. The American Journal of Psychiatry, 157, 1925–1932. https://doi.org/10.1176/appi.ajp.157.12.1925

Article  PubMed  Google Scholar 

Cerimele, J. M., Fortney, J. C., & Unützer, J. (2017). Bipolar disorder and population health. Psychiatric Services, 68, 192–194. https://doi.org/10.1176/appi.ps.201600011

Article  PubMed  Google Scholar 

Colla, B. D. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet Psychiatry, 9, 137–150. https://doi.org/10.1016/S2215-0366(21)00395-3

Article  Google Scholar 

Correll, C. U., Rubio, J. M., Inczedy-Farkas, G., Birnbaum, M. L., Kane, J. M., & Leucht, S. (2017). Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence. JAMA Psychiatry, 74, 675–684. https://doi.org/10.1001/jamapsychiatry.2017.0624

Article  PubMed  PubMed Central  Google Scholar 

Correll, C. U., Solmi, M., Cortese, S., Fava, M., Højlund, M., Kraemer, H. C., McIntyre, S. R., Pine, D. S., & Kane, J. M. (2023). The future of psychopharmacology: A critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents. World Psychiatry, 22, 48–74. https://doi.org/10.1002/wps.21056

Article  PubMed  PubMed Central  Google Scholar 

Cortese, S., Purper-Ouakil, D., Apter, A., Arango, C., Baeza, I., Banaschewski, T., & Moreno, C. (2024). Psychopharmacology in children and adolescents: Unmet needs and opportunities. The Lancet Psychiatry, 11, 143–154. https://doi.org/10.1016/S2215-0366(23)00345-0

Article  PubMed  Google Scholar 

De Crescenzo, F., D’Alò, G. L., Ostinelli, E. G., Ciabattini, M., Di Franco, V., Watanabe, N., & Cipriani, A. (2022). Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: A systematic review and network meta-analysis. The Lancet, 400, 170–184. https://doi.org/10.1016/S0140-6736(22)00878-9

Article  Google Scholar 

Dwyer, J. B., Aftab, A., Radhakrishnan, R., Widge, A., & Rodriguez, C. I. (2020). Hormonal treatments for major depressive disorder: State of the art. American Journal of Psychiatry, 177, 686–705. https://doi.org/10.1176/appi.ajp.2020.19080848

Article  PubMed  Google Scholar 

Fountoulakis, K. N., Kasper, S., Andreassen, O., Blier, P., Okasha, A., Severus, E., Versiani, M., Tandon, R., Möller, H., & Vieta, E. (2012). Efficacy of pharmacotherapy in bipolar disorder: A report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience, 262, 1–48. https://doi.org/10.1007/s00406-012-0323-x

Article  PubMed  Google Scholar 

Gerlach, M., & Warnke, A. (2014). Anxiolytics and sedative-hypnotics. Psychiatric Drugs in Children and Adolescents, 6, 219–255. https://doi.org/10.1007/978-3-7091-1501-5_6

Article  Google Scholar 

Gibbons, R. D., Brown, C. H., Hur, K., Davis, J. M., & Mann, J. J. (2012). Suicidal thoughts and behavior with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry, 69, 580–587. https://doi.org/10.1001/archgenpsychiatry.2011.2048

Article  PubMed  PubMed Central  Google Scholar 

Goes, F. S. (2023). Diagnosis and management of bipolar disorders. British Medical Journal, 381, e073591. https://doi.org/10.1136/bmj-2022-073591

Article  PubMed  Google Scholar 

Gomes, F. A., Cerqueira, R. O., Lee, Y., Mansur, R. B., Kapczinski, F., McIntyre, R. S., & Brietzke, E. (2022). What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines. Journal of Affective Disorders, 298, 565–576. https://doi.org/10.1016/j.jad.2021.11.007

Article  PubMed  Google Scholar 

Jacob, K. S., & Patel, V. (2014). Classification of mental disorders: A global mental health perspective. The Lancet, 383, 1433–1435. https://doi.org/10.1016/S0140-6736(13)62382-X

Article  Google Scholar 

Katie, K. (2024). FDA approves first schizophrenia drug with new mechanism of action since 1950s. Nature Reviews Drug Discovery, 23, 803. https://doi.org/10.1038/d41573-024-00155-8

Article  Google Scholar 

Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. U. (2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research, 21, 169–184. https://doi.org/10.1002/mpr.1359

Article  PubMed  PubMed Central  Google Scholar 

Koyuncu, A., Ayan, T., Ince Guliyev, E., Erbilgin, S., & Deveci, E. (2022). ADHD and anxiety disorder comorbidity in children and adults: Diagnostic and therapeutic challenges. Current Psychiatry Reports, 24, 129–140. https://doi.org/10.1007/s11920-022-01324-5

Article  PubMed  Google Scholar 

Li, H., Gao, J., Song, H., Yang, X., Li, C., Zhang, Y., Wang, J., Liu, Y., Wang, D., & Li, H. (2024). Changes in the medial prefrontal cortex metabolites after 6 months of medication therapy for patients with bipolar disorder: A H-MRS study. CNS Neuroscience & Therapeutics, 30, e70048. https://doi.org/10.1111/cns.70048

Article  Google Scholar 

Lin, S. K., Yang, S. Y., Park, S. C., Jang, O. J., Zhu, X., Xiang, Y. T., & Shinfuku, N. (2022). Prescription patterns for bipolar disorder in Asian countries: Findings from research on Asian prescription pattern-bipolar disorder. Clinical Psychopharmacology and Neuroscience, 20, 61–69. https://doi.org/10.9758/cpn.2022.20.1.61

Article  PubMed  PubMed Central  Google Scholar 

McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia-an overview. JAMA Psychiatry, 77, 201–210. https://doi.org/10.1001/jamapsychiatry.2019.3360

Article  PubMed  Google Scholar 

Moreno, C., Arango, C., Parellada, M., Shaffer, D., & Bird, H. (2007). Antidepressants in child and adolescent depression: Where are the bugs? Acta Psychiatrica Scandinavica, 115, 184–195. https://doi.org/10.1111/j.1600-0447.2006.00951.x

Article  PubMed  Google Scholar 

Oh, S., Lee, T. Y., Kim, M., Kim, S. H., Lee, S., Cho, S., Kim, J. H., & Kwon, J. S. (2020). Effectiveness of antipsychotic drugs in schizophrenia: A 10-year retrospective study in a Korean tertiary hospital. Nature Partner Journal Schizophrenia, 6, 32. https://doi.org/10.1038/s41537-020-00122-3

Article  Google Scholar 

Park, J. H., Fernando, K., Park, Y. H., & Park, E. O. (2024). Global perspectives on bipolar disorder treatment: In-depth comparative analysis of international guidelines for medication selection. British Journal of Pharmacology Open, 10, e75. https://doi.org/10.1192/bjo.2024.27

Article  Google Scholar 

Paul, S. M., & Potter, W. Z. (2024). Finding new and better treatments for psychiatric disorders. Neuropsychopharmacology, 49, 3–9. https://doi.org/10.1038/s41386-023-01690-5

Article  PubMed  Google Scholar 

Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015). Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Annual Research Review, 56, 345–365. https://doi.org/10.1111/jcpp.12381

Article  Google Scholar 

Pollock, C., Grenyer, B. F. S., & Townsend, M. L. (2024). Responding to suicidal behaviour in children and young people with a child maltreatment history: A scoping review. Children and Youth Services Review, 166, 107927. https://doi.org/10.1016/j.childyouth.2024.107927

Article  Google Scholar 

Clackler, R., Felton, K., Holmes, S. A., Stabinsky, H. N., & Yarbrough, N. B. (2020). Bipolar disorder. The New England Journal of Medicine, 383, 58–66. https://doi.org/10.1056/NEJMra1906193

Article  Google Scholar 

Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019). Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis. The Lancet, 393, 768–777. https://doi.org/10.1016/S0140-6736(18)31793-8

Article  Google Scholar 

Smogur, M., Onesanu, A., Plessen, K. J., Eap, C. B., & Ansermot, N. (2022). Psychotropic drug prescription in children and adolescents: Approved medications in European countries and the United States. Journal of Child and Adolescent Psychopharmacology, 32, 80–88. https://doi.org/10.1089/cap.2021.0027

Article  PubMed  Google Scholar 

Solmi, M., Radua, J., Olivola, M., Croce, E., Soardo, L., Pablo, G., Shin, J., Kirkbride, J. B., Jones, P., Kim, J. H., Kim, J. Y., Carvalho, A. F., Seeman, M. V., Correll, C. U., & Poli, P. F. (2022). Age at onset of mental disorders worldwide: Large-scale meta-analysis of 192 epidemiological studies. Molecular Psychiatry, 27, 281–295. https://doi.org/10.1038/s41380-021-01161-7

Article  PubMed  Google Scholar 

Song, M., Ware, R. S., Doan, T. N., McPherson, L., Trollor, J. N., & Harley, D. (2020). Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia. British Journal of Pharmacology Open, 6, e142. https://doi.org/10.1192/bjo.2020.125

Article  Goog